| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.93B | 1.92B | 2.40B | 2.13B | 2.02B | 2.28B |
| Gross Profit | 887.43M | 859.10M | 1.10B | 996.11M | 947.04M | 975.93M |
| EBITDA | 374.27M | 374.08M | 553.97M | 453.35M | 398.04M | 660.15M |
| Net Income | 216.46M | 198.01M | 350.77M | 252.64M | 200.94M | 461.82M |
Balance Sheet | ||||||
| Total Assets | 5.01B | 4.88B | 5.36B | 5.60B | 5.81B | 5.44B |
| Cash, Cash Equivalents and Short-Term Investments | 4.17B | 4.02B | 4.12B | 3.55B | 3.36B | 3.48B |
| Total Debt | 903.20M | 963.33M | 1.31B | 1.70B | 1.95B | 1.64B |
| Total Liabilities | 1.29B | 1.35B | 1.79B | 2.21B | 2.51B | 2.20B |
| Stockholders Equity | 3.72B | 3.53B | 3.57B | 3.39B | 3.30B | 3.24B |
Cash Flow | ||||||
| Free Cash Flow | 370.94M | -213.83M | 361.22M | 378.15M | 426.54M | 765.01M |
| Operating Cash Flow | 393.69M | -188.90M | 385.64M | 426.56M | 467.20M | 787.63M |
| Investing Cash Flow | 335.63M | 623.04M | 606.44M | 104.31M | -585.53M | -74.19M |
| Financing Cash Flow | -200.81M | -618.14M | -666.91M | -591.63M | -107.50M | -774.98M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.43B | 4.06 | 5.10% | 4.05% | 6.60% | -14.32% | |
73 Outperform | HK$14.23B | 5.90 | 9.54% | 4.43% | 10.89% | 2.02% | |
64 Neutral | HK$110.79B | 15.23 | 23.74% | 4.21% | -9.49% | 32.56% | |
62 Neutral | HK$2.22B | 3.36 | 5.92% | 7.71% | -7.48% | -16.11% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$8.58B | 1.57 | 9.13% | 4.60% | -10.41% | 67.25% | |
48 Neutral | HK$391.67M | -11.47 | -7.92% | ― | -18.07% | -1041.89% |